On July 16, Stroke Care Technology announced the completion of tens of millions of US dollars in a Series C financing round.
The round was co-invested by LYFE Capital and Sherpa Venture Capital, with DAS Capital continuing to serve as the sole financial advisor.
The successful completion of this round of financing will promote the clinical advancement of the new products of Stroke Care Technology's five product lines,and the accelerated marketing and industrialization of the upcoming products.
Founded in 2016, Stroke Care Technology is a developer of a medical technology designed to provide minimally invasive treatment products.
The company focuses on the development of minimally invasive treatment products for ischemic stroke prevention and treatment and provides users with cardio-cerebral vascular health solutions, enabling clients to facilitate medical treatment efficiency and improve patients' health condition.